RNU6-783P

Across TCGA pan-cancer cohorts, RNU6-783P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RNU6-783P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-783P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-783P expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

KIRC, SKCM, and PAAD are the cancer types where RNU6-783P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	All	0.422	0.664	<.001	84	view →
SKCM	OS	Tertile	II,III,IV	0.225	0.745	<.001	57	view →
PAAD	DFS	Tertile	All	0.118	0.468	.012	45	view →
LUSC	OS	Tertile	All	0.133	0.762	<.001	36	view →
LIHC	DFS	Tertile	All	0.198	0.561	.001	36	view →
BLCA	DFS	Tertile	All	0.173	0.519	.049	9	view →
LGG	OS	Tertile	All	0.374	0.799	.037	9	view →
STAD	OS	Quartile	IV	0.820	0.278	.037	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RNU6-783P–KIRC (DFS)

Open the KIRC breakdown →